Related Experiment Video
Updated: Aug 12, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
Mutations in the acid alpha-glucosidase gene (M. Pompe) in a patient with an unusual phenotype
J M H Anneser1, D E Pongratz, T Podskarbi
1Department of Neurology and Friedrich-Baur-Institute, Ludwig-Maximilians-University, Munich, Germany. Johanna.Anneser@nro.med.uni-muenchen.de
Abstract:
Glycogenosis type II (Pompe disease) is a lysosomal storage disease caused by deficiency of acid alpha-glucosidase (acid maltase). The disease is autosomal recessive inherited and is clinically and genetically heterogenous. The authors describe a 30-year-old woman affected by late-onset Pompe disease with vascular affection resembling atherosclerotic angiopathy of the elderly. Genetic analysis revealed two novel mutations (Ala237Val and Gly293Arg) in the acid alpha-glucosidase gene in this patient.
Insights
Late-onset Pompe disease, a lysosomal storage disorder, presented unusually in a 30-year-old woman with vascular issues. Genetic analysis identified two new mutations in the acid alpha-glucosidase gene.
Area of Science:
- Biochemistry
- Genetics
- Rare Diseases
Background:
- Glycogenosis type II, also known as Pompe disease, is a rare autosomal recessive lysosomal storage disorder.
- It results from a deficiency in the enzyme acid alpha-glucosidase (acid maltase).
- Pompe disease exhibits significant clinical and genetic heterogeneity.
Observation:
- A 30-year-old woman presented with late-onset Pompe disease.
- Her clinical presentation included vascular affection that mimicked atherosclerotic angiopathy typically seen in the elderly.
- This atypical presentation highlights the diverse manifestations of Pompe disease.
Findings:
- Genetic analysis of the patient revealed two previously unidentified mutations in the acid alpha-glucosidase gene.
- The specific mutations identified were Ala237Val and Gly293Arg.
- These novel mutations provide new insights into the genetic basis of Pompe disease.
Implications:
- The findings expand the known spectrum of mutations associated with Pompe disease.
- Understanding these novel mutations may aid in developing more targeted diagnostic and therapeutic strategies.
- This case underscores the importance of considering Pompe disease in patients with unexplained vascular conditions, even in younger individuals.
Related Concept Videos
Pleiotropy
Lysosomal Hydrolases
Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Abnormal Proliferation
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Inborn Errors of Metabolism

